Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

21.37
Delayed Data
As of 3:59pm ET
 +0.46 / +2.20%
Today’s Change
3.64
Today|||52-Week Range
23.49
+43.33%
Year-to-Date
Why Exelixis Is Already Up 55% This Year
Mar 15 / MotleyFool.com - Paid Partner Content
The 3 Most Important Numbers for Exelixis, Inc.
Mar 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close20.91
Today’s open20.65
Day’s range20.30 - 21.44
Volume3,930,855
Average volume (3 months)5,476,774
Market cap$6.1B
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+118.30%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratioNM
Price/Sales19.51
Price/Book67.87

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+0.03+0.04%
CRLCharles River Labora...+0.34+0.39%
PRAHPRA Health Sciences ...+1.52+2.46%
PRXLPAREXEL Internationa...+0.07+0.11%
Data as of 4:02pm ET, 03/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs